
    
      Hypothesis testing will be used to determine the patient number in this study. According to a
      preliminary data at CGMH-LK, the investigators have the untreated patients with population
      prevalence of critical weight loss that is 0.56, and the investigators assume the study
      treated population prevalence is 0.4, power set in 0.9, alpha set in 0.05.
    
  